Disadvantage and neurocognitive comorbidities in childhood idiopathic epilepsies

William A Schraegle1,2, Rebecca F Slomowitz2, Carson Gundlach3

  • 1Departments of Neurology and Pediatrics, Dell Medical School, University of Texas at Austin, Austin, Texas, USA.

Epilepsia
|March 25, 2023
PubMed

Insights

Neighborhood disadvantage significantly impacts cognitive and academic abilities in children with epilepsy. Socioeconomic hardship exacerbates these challenges, highlighting the need for integrated care models.

Area of Science:

  • Neuroscience
  • Pediatrics
  • Public Health

Background:

  • Neighborhood disadvantage is a key social determinant of health.
  • Its impact on cognitive function in pediatric epilepsy is not well understood.
  • Understanding this relationship is crucial for addressing neurobehavioral comorbidities.

Purpose of the Study:

  • To investigate the association between neighborhood disadvantage and cognitive function in children with new-onset idiopathic epilepsy.
  • To examine clinical, sociodemographic, and family factors in relation to cognitive function.
  • To compare children with epilepsy to healthy controls.

Main Methods:

  • 288 children (8-18 years) with recent onset epilepsy (n=182) and healthy controls (n=106) participated.
  • A comprehensive neuropsychological battery assessed cognitive abilities.
  • Neighborhood Atlas provided Area Deprivation Index (ADI) based on residential addresses.

Main Results:

  • High neighborhood disadvantage was linked to lower IQ, impaired expressive language, and reduced verbal recall in children with epilepsy.
  • Cognitive function in healthy controls was not affected by disadvantage.
  • Children with epilepsy showed greater academic difficulties, worsened by disadvantage.

Conclusions:

  • Socioeconomic hardship adversely affects cognitive and academic status in youth with epilepsy.
  • Neighborhood disadvantage is a significant factor in the neurobehavioral comorbidities of epilepsy.
  • Etiological models must incorporate socioeconomic factors to understand epilepsy comorbidities.
Abstract

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
234
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
486
Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
135
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
452
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
484
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
232